Drug Topics April 2020

As the global COVID-19 pandemic and consequent public health crisis continues on, health care providers on the frontlines of this crisis deserve all of the support needed to continue serving their patients.

“You’re basically on call 24/7, 365 days a year. That’s the biggest word of caution I would offer to someone considering this. But at the same time, the biggest reward I get is seeing sick people get better."

This year may mark a dramatic difference in the development and approval of complex generic drug products.

“I had been practicing for 4 years at that time and longed for the day that pharmacists would have input in patient’s pharmacotherapy. That day is here!”

In 2010, nearly 43 million of adults living in the United States, or approximately 20%, took aspirin a minimum of 3 times per week for 3 months or more.

What does it mean for patients?

Pharmacists are positioned to play a key role in preventing or catching errors that can occur at the various stages of the drug-use process: prescribing, dispensing, and administration.

Pharmacies that haven’t added digital marketing and advertising to their mix are missing the target.

The FDA has approved lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) for treatment of schizophrenia in adults.

Pharmacists can play an integral role in managing patients with diabetes.

Pharmacists weigh in on how to bring this generation to the pharmacy.

Perspectives from pharmacy associations in the states hardest hit with the COVID-19 outbreak.

More than one-third of all children in the United States are not following the recommended vaccine schedule, according to a new study.

Strategies for seizing revenue opportunities outside of the PBM.

Advil Dual Action, an ibuprofen and acetaminophen fixed-dose combination, has been approved as an OTC product for pain relief.

Boost your financial IQ with these tips on how to manage your budget and increase cash flow.

Kevin DeMass, RPh, is the owner and leader of a talented team of professionals that encounters a wide variety of patients, ailments, and medications.

In new comments to the US government, several pharmacy groups say that mergers of major companies have had significant anticompetitive effects without improving the cost and quality of health care.

Buying a pharmacy? Here's what you need to know about depreciation and amortization.